FENNEC PHARMACEUTICALS INC. (FENC)

Every figure this model derived for FENC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2014-09-30
cash 41,249,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 72,500,000 AssetsCurrent 2026-06-30
current liabilities 12,394,000 LiabilitiesCurrent 2026-06-30
equity 42,442,000 StockholdersEquity 2026-06-30
interest expense 904,000 InterestExpenseDebt 2026-06-30
ocf -2,040,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 59,221,000 Revenues 2026-06-30
sbc 7,505,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up FENC on one particular measure came for.

RatioValue
cash operating margin10.77
current ratio7.87
current ratio reported5.85
deferred revenue growth1183.06
dilution pct4.7
fcf margin-3.44
growth cv0.95
interest cover-1.24
operating margin-1.9
owner earnings margin-16.12
revenue growth77.83
revenue growth per share69.84
roic-74.5
rule of 4075.93
sbc pct revenue12.67

What to be careful about

What this model itself distrusts about FENC's figures. Written by the derivation as it ran, not added afterwards.